Women who received the HPV vaccine after surgical excision for high-grade cervical dysplasia had lower risk for recurrence than women who received placebo or surgery alone, according to results of a ...

Only 45.5% of patients completed guideline-concordant surveillance within 30 months after treatment for high-grade cervical dysplasia, with one third of those receiving abnormal co-test results. Among ...

Please provide your email address to receive an email when new articles are posted on . Only 45.5% of women treated for high-grade cervical dysplasia completed two surveillance co-tests within 30 ...

INOVIO also continues to partner with QIAGEN to develop a pre-treatment predictive biomarker with the goal of identifying women expected to respond to VGX-3100 PLYMOUTH MEETING, Pa., March 1, 2021 ...

Self-Efficacy and Willingness to Implement Narrative Communication Interventions: Mixed Methods Study Among Breast Cancer Patients and Survivors at the University College Hospital, Ibadan, Nigeria ...

HRME demonstrated an accurate in-situ diagnosis of high-grade dysplasia. In low-resource settings in which colposcopy and histopathology services are severely limited or unavailable, HRME may provide ...

Wendy R. Brewster, M.D., Ph.D., of the University of California, Irvine, and colleagues developed a cancer control program to simplify cervical screening and management of high-grade cervical ...

PLYMOUTH MEETING, Pa., Aug. 19, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has completed enrollment in the company's open-label, 24 patient, Phase 2 trial ...

I had a Pap test recently, and my doctor said the results showed cervical dysplasia. What does that mean? Is it cancer? Answer From Shannon K. Laughlin-Tommaso, M.D. No. Cervical dysplasia isn't ...

PLYMOUTH MEETING, Pa., March 1, 2021 /PRNewswire/ -- INOVIO, (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from ...